Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Purpose: To investigate the impact of milk protein ingestion on resistance exercise-induced muscle damage in untrained males and females.
Rationale: Unaccustomed resistance exercise can cause muscle damage, presenting as muscle soreness and reduced muscle function - such as loss of strength, power, and flexibility - for several days after the exercise bout. Therefore, individuals may require longer recovery periods before performing another exercise bout, and their performance may be impaired. Further, muscle soreness may reduce exercise compliance, particularly in novice individuals. Over time, this may compromise the gains in muscle mass and strength achieved through exercise training. Therefore, strategies to reduce the severity of exercise-induced muscle damage and/or to enhance post-exercise recovery processes are advantageous for exercising individuals.
One such strategy is the consumption of dietary protein before or after muscle-damaging exercise, which has shown to alleviate muscle soreness, improve blood markers of muscle damage, and reduce the decline in maximal force and flexibility. In particular, consuming 20-gram doses of milk protein in the days after resistance exercise can improve the recovery time of muscle soreness and maximum force, and also lower levels of damage markers in the blood. However, most studies have been conducted with male participants who are well-trained in resistance exercise. It has been suggested that males and females respond differently to muscle damage, and therefore, this research aims to provide a sex comparison in the muscle damage response to an acute bout of resistance exercise with or without milk protein feeding.
Therefore, 40 healthy, young (18-35 years) adults (20 males, 20 females) will be recruited to participate in this randomised controlled trial. Maximal leg strength and body composition (by dual-energy X-ray absorptiometry; DXA) will be conducted at baseline. In females, all primary outcome measures will be obtained during the late follicular phase of the menstrual cycle. Participants will then be randomised to a protein (dairy yoghurt) or placebo (oat-based yoghurt) dietary condition.
Three weeks later, participants will complete a high-intensity resistance exercise session on leg extension and leg curl machines to induce muscle damage. Various measures of muscle damage (blood biomarkers, muscle soreness, flexibility, and swelling) will be obtained before, immediately after, and 24, 48, 72, and 168 h after the exercise protocol. The maximal strength test will be repeated 72 and 168 h after the exercise. Participants will consume the protein or placebo yoghurt 4 times per day (every 3-4 hours) on the day of the exercise bout and the following 3 days. Participants' habitual activity and dietary intake will be monitored and controlled throughout the study period.
Expected outcome: It is expected that the resistance exercise protocol will induce muscle damage, which will be attenuated with the ingestion of milk protein. It cannot be ascertained whether males and females will have the same responses to the exercise or to protein ingestion.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Milk Protein | Experimental | 4 daily 20-gram doses of milk protein (dairy yoghurt) consumed for 4 consecutive days after the exercise bout |
|
| Placebo | Placebo Comparator | 4 daily doses of low-protein placebo product (oat-based yoghurt) consumed for 4 consecutive days after the exercise bout |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Resistance exercise | Other | Acute leg-based resistance exercise bout performed at 80% 1RM (4 sets to volitional failure on leg extension and leg curl machines) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximal Voluntary Contraction at baseline | One-repetition maximum (1RM) test: leg extension and leg curl machines | Baseline |
| Change from baseline Maximal Voluntary Contraction at 72-hours post-exercise | One-repetition maximum (1RM) test: leg extension and leg curl machines | 72-hours after the exercise bout |
| Change from baseline Maximal Voluntary Contraction at 168-hours post-exercise | One-repetition maximum (1RM) test: leg extension and leg curl machines | 168-hours after the exercise bout |
| Creatine kinase concentration at baseline | Serum concentration of creatine kinase from venous blood sampling | Immediately pre-exercise |
| Change from baseline in Creatine Kinase concentration immediately post-exercise | Serum concentration of creatine kinase from venous blood sampling | Immediately after the exercise bout |
| Change from baseline in Creatine Kinase concentration at 24-hours post-exercise | Serum concentration of creatine kinase from venous blood sampling | 24-hours after the exercise bout |
| Change from baseline in Creatine Kinase concentration at 48-hours post-exercise | Serum concentration of creatine kinase from venous blood sampling |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alice G Pearson | Contact | 07771357222 | alice.g.pearson@durham.ac.uk | |
| Lindsay S Macnaughton | Contact | lindsay.s.macnaughton@durham.ac.uk |
| Name | Affiliation | Role |
|---|---|---|
| Alice G Pearson | Durham University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Durham University, Sports and Wellbeing Park | Recruiting | Durham | DH1 3HN | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D063806 | Myalgia |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D055070 | Resistance Training |
| ID | Term |
|---|---|
| D005081 | Exercise Therapy |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 48-hours after the exercise bout |
| Change from baseline in Creatine Kinase concentration at 72-hours post-exercise | Serum concentration of creatine kinase from venous blood sampling | 72-hours after the exercise bout |
| Change from baseline in Creatine Kinase concentration at 168-hours post-exercise | Serum concentration of creatine kinase from venous blood sampling | 168-hours after the exercise bout |
| Interleukin-6 concentration at baseline | Serum concentration of Interleukin-6 from venous blood sampling | Immediately pre-exercise |
| Change from baseline in Interleukin-6 concentration immediately post-exercise | Serum concentration of Interleukin-6 from venous blood sampling | Immediately after the exercise bout |
| Change from baseline in Interleukin-6 concentration at 24-hours post-exercise | Serum concentration of Interleukin-6 from venous blood sampling | 24-hours after the exercise bout |
| Change from baseline in Interleukin-6 concentration at 48-hours post-exercise | Serum concentration of Interleukin-6 from venous blood sampling | 48-hours after the exercise bout |
| Change from baseline in Interleukin-6 concentration at 72-hours post-exercise | Serum concentration of Interleukin-6 from venous blood sampling | 72-hours after the exercise bout |
| Change from baseline in Interleukin-6 concentration at 168-hours post-exercise | Serum concentration of Interleukin-6 from venous blood sampling | 168-hours after the exercise bout |
| Muscle soreness (pressure algometry) at baseline | Self-perceived rating of muscle soreness with use of pressure algometry | Immediately pre-exercise |
| Change in muscle soreness (pressure algometry) immediately post-exercise | Self-perceived rating of muscle soreness with use of pressure algometry | Immediately after the exercise bout |
| Change in muscle soreness (pressure algometry) at 24-hours post-exercise | Self-perceived rating of muscle soreness with use of pressure algometry | 24-hours after the exercise bout |
| Change in muscle soreness (pressure algometry) at 48-hours post-exercise | Self-perceived rating of muscle soreness with use of pressure algometry | 48-hours after the exercise bout |
| Change in muscle soreness (pressure algometry) at 72-hours post-exercise | Self-perceived rating of muscle soreness with use of pressure algometry | 72-hours after the exercise bout |
| Change in muscle soreness (pressure algometry) at 168-hours post-exercise | Self-perceived rating of muscle soreness with use of pressure algometry | 168-hours after the exercise bout |
| Muscle soreness (VAS) at baseline | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | Immediately pre-exercise |
| Change in muscle soreness (VAS) immediately post-exercise | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | Immediately after the exercise bout |
| Change in muscle soreness (VAS) at 24-hours post-exercise | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | 24-hours after the exercise bout |
| Change in muscle soreness (VAS) at 48-hours post-exercise | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | 48-hours after the exercise bout |
| Change in muscle soreness (VAS) at 72-hours post-exercise | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | 72-hours after the exercise bout |
| Change in muscle soreness (VAS) at 168-hours post-exercise | Self-perceived rating of muscle soreness while performing a bodyweight squat with use of a visual analogue scale | 168-hours after the exercise bout |
| Range of motion at baseline | Flexibility of the exercised limb as determined by goniometry | Immediately pre-exercise |
| Change in range of motion immediately post-exercise | Flexibility of the exercised limb as determined by goniometry | Immediately after the exercise bout |
| Change in range of motion at 24-hours post-exercise | Flexibility of the exercised limb as determined by goniometry | 24-hours after the exercise bout |
| Change in range of motion at 48-hours post-exercise | Flexibility of the exercised limb as determined by goniometry | 48-hours after the exercise bout |
| Change in range of motion at 72-hours post-exercise | Flexibility of the exercised limb as determined by goniometry | 72-hours after the exercise bout |
| Change in range of motion at 168-hours post-exercise | Flexibility of the exercised limb as determined by goniometry | 168-hours after the exercise bout |
| Limb circumference at baseline | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | Immediately pre-exercise |
| Change in limb circumference immediately post-exercise | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | Immediately after the exercise bout |
| Change in limb circumference at 24-hours post-exercise | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | 24-hours after the exercise bout |
| Change in limb circumference at 48-hours post-exercise | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | 48-hours after the exercise bout |
| Change in limb circumference at 72-hours post-exercise | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | 72-hours after the exercise bout |
| Change in limb circumference at 168-hours post-exercise | Measure of leg circumference with use of standard anthropometric tape to indicate muscle swelling | 168-hours after the exercise bout |
| D059352 | Musculoskeletal Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D005791 |
| Patient Care |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |